The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of a nivolumab (nivo)-containing regimen in patients (pts) with newly diagnosed classical Hodgkin lymphoma (cHL): Study 205 Cohort D.
 
Philippe Armand
Consulting or Advisory Role - Bristol-Myers Squibb; Infinity Pharmaceuticals; Merck Sharp & Dohme
Research Funding - Bristol-Myers Squibb; Merck Sharp & Dohme; Otsuka; Sequenta; Sigma-Tau; Tensha Therapeutics
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Sequenta
 
Margaret Ann Shipp
Honoraria - Bristol-Myers Squibb; Gilead Sciences; Merck; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Merck; Takeda
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst)
 
John Kuruvilla
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Lundbeck; Merck; Roche; Seagen
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Janssen; Roche; Seagen
Research Funding - Celgene; Jesse & Julie Rasch Foundation; Karyopharm Therapeutics; Leukemia and Lymphoma Society; Roche
Other Relationship - Lymphoma Canada
 
Graham P Collins
Honoraria - Gilead Sciences; Roche; Takeda
Consulting or Advisory Role - Gilead Sciences; Roche; Takeda
Speakers' Bureau - Gilead Sciences; Takeda
Research Funding - Celgene
Travel, Accommodations, Expenses - NAPP Pharmaceuticals; Roche
 
Rod Ramchandren
Research Funding - Janssen; Pharmacyclics; Seagen
 
John Timmerman
Stock and Other Ownership Interests - Biomarin; Medivation
Honoraria - Ono Pharmaceutical
Research Funding - Bristol-Myers Squibb; ImmunGene; Janssen Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Anne Sumbul
Employment - Bristol-Myers Squibb
 
Mary M. Ruisi
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Kazunobu Kato
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Stephen Maxted Ansell
Honoraria - Research to Practice; WebMD
Research Funding - Bristol-Myers Squibb (Inst); Celldex (Inst); Seagen (Inst)